SLNO
Soleno Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q1 2026 | 81 | -6 | 38.38M | $1.28B | +6 | −12 |
| Q4 2025 | 86 | 0 | 43.97M | $2.04B | +1 | −1 |
| Q3 2025 | 17 | -1 | 29.19M | $1.97B | — | −1 |
| Q2 2025 | 15 | -1 | 21.84M | $1.83B | +1 | −2 |
| Q1 2025 | 13 | +4 | 13.32M | $951.87M | +4 | — |
| Q4 2024 | 9 | 0 | 8.99M | $404.33M | — | — |
| Q3 2024 | 8 | 0 | 6.39M | $322.73M | +2 | −2 |
| Q2 2024 | 8 | — | 4.85M | $197.82M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 4.39M | +58.2% | $313.86M | 0.6% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.40M | +47.2% | $171.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.40M | +47.2% | $171.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.58M | +62.1% | $112.61M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.58M | +62.1% | $112.61M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passive) | 1.17M | -13.2% | $83.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 916.00K | New | $65.45M | 0.2% | New | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 679.29K | +42.5% | $48.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passive) | 615.74K | +2.8% | $44.00M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passive) | 615.74K | +2.8% | $44.00M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Capital World Investors ✦ | 464.83K | New | $33.21M | 0.0% | New | 1 | SEC ↗ |
| 19 | Soros Fund Management ✦ | 270.66K | New | $19.34M | 0.5% | New | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 123.75K | -69.0% | $8.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Marshall Wace ✦ | 123.75K | -69.0% | $8.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 16.67K | New | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 3.11K | -71.0% | $222,425 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 3.11K | -71.0% | $222,425 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 3.11K | -71.0% | $222,425 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $65.45M | 0.2% |
| Capital World Investors | $33.21M | 0.0% |
| Soros Fund Management | $19.34M | 0.5% |
| D. E. Shaw & Co. | $1.19M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 224 holders, 55.22M shares, $1.81B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.